Table 3 Incidence Rates and Risks of AVF/AVG Dysfunction in ADPKD and Non-ADPKD Groups With or Without Diabetes Mellitus.

From: Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease

Patient Group

No. of Events

Person- Years

Incidence Rate*

Crude

Competing Risk

HR (95% CI)

P

SHR (95% CI)

P

Non-ADPKD group without diabetes mellitus

724

3914

18.50

Reference

Reference

Non-ADPKD group with diabetes mellitus

299

907

32.98

2.87 (1.84–4.49)

<0.001

1.43 (1.25–1.64)

<0.001

ADPKD group without diabetes mellitus

263

1129

23.30

1.18 (0.67–2.06)

0.565

1.18 (1.03–1.36)

0.015

ADPKD group with diabetes mellitus

108

332

32.58

2.60 (1.37–4.94)

0.003

1.43 (1.16–1.76)

0.001

  1. *Per 102 person-years.
  2. Abbreviations: AVF, arteriovenous fistula; AVG, arteriovenous graft; ADPKD, autosomal dominant polycystic kidney disease; HR, hazard ratio; SHR, subdistribution hazard ratio; CI, confidence interval.
Back to article page